Learning about cancer clinical trials for interested adults
Part of Blood & lymphatic, Cancer clinical trials.
This study aims to help people learn more about cancer clinical trials and become more comfortable with the idea of joining one. It is open to adults connected to Karmanos Cancer Institute who want to learn and give their permission to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or older
- You are connected to Karmanos Cancer Institute—either as a patient or through a community event they sponsor
- You have expressed interest in taking part and will sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a virtual community health educator to help cancer patients and their caregivers learn more about and join clinical trials. If you have had cancer or care for someone who has, this program might help you find trials that fit.
This study aims to identify and overcome barriers that prevent underserved groups from joining cancer trials. It involves working with patients, doctors, and hospitals to make clinical trials more accessible.
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
This study tests an educational program to help patients with advanced cancer talk about their goals of care. The goal is to make sure your wishes are known and respected by your care team.
This study helps people learn about clinical trials and find out if they might be a good fit. It is for patients who are already getting treatment at a Karmanos or McLaren center and can read English well enough to complete surveys.
This study looks at how doctors and patients talk about clinical trials, with the goal of improving conversations for everyone involved. If you join, you'll fill out questionnaires about your experiences.
Hear when a new Hematopoietic and Lymphoid Cell Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.